Avanos Medical
AVNS
AVNS was delisted on the 24th of July, 2026.
287 hedge funds and large institutions have $1.1B invested in Avanos Medical in 2022 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 73 increasing their positions, 79 reducing their positions, and 29 closing their positions.
94% more call options, than puts
Call options by funds: $68K | Put options by funds: $35K
69% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 29
16% more capital invested
Capital invested by funds: $942M → $1.1B (+$154M)
6% more funds holding
Funds holding: 272 → 287 (+15)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 79
6% less ownership
Funds ownership: 93% → 87% (-6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WHG
Westwood Holdings Group
Dallas,
Texas
|
+$11.5M |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$6.94M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.29M |
| 4 |
BlackRock
New York
|
+$4.63M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$3.83M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$19.6M |
| 2 |
Goldman Sachs
New York
|
-$5.34M |
| 3 |
RC
RGM Capital
Naples,
Florida
|
-$3.06M |
| 4 |
D.E. Shaw & Co
New York
|
-$2.52M |
| 5 |
Nuveen
Charlotte,
North Carolina
|
-$1.9M |
AVNS Hedge Fund Activity: Q4 2022 in Review
287 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q4 2022, worth a combined $1.1B — up 16% from $942M a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new AVNS positions and 29 closed out — a net gain of 20 holders — while 73 added to existing stakes and 79 trimmed.
The largest buyer was Westwood Holdings Group, adding an estimated $11.5M. The largest seller was Millennium Management, cutting an estimated $19.6M.
- 287 institutional investors held Avanos Medical (AVNS) as of Q4 2022, up from 272 in Q3 2022.
- Funds reported $1.1B of Avanos Medical stock for Q4 2022, up 16% quarter-over-quarter.
- 49 funds opened new Avanos Medical positions in Q4 2022 and 29 closed out, a net change of +20 holders.
- The largest Avanos Medical buyer in Q4 2022 was Westwood Holdings Group, an estimated $11.5M added.
- The largest Avanos Medical seller in Q4 2022 was Millennium Management, an estimated $19.6M sold.
Based on aggregated 13F filings for Q4 2022.